A comparative analysis of platelet-rich plasma alone versus combined with extracorporeal shockwave therapy in athletes with patellar tendinopathy and knee pain: a randomized controlled trial
2024

Comparing Treatments for Knee Pain in Athletes

Sample size: 33 publication 10 minutes Evidence: moderate

Author Information

Author(s): Jhan Shun-Wun, Wu Kuan-Ting, Chou Wen-Yi, Chen Po-Cheng, Wang Ching-Jen, Huang Wen-Chiung, Cheng Jai-Hong

Primary Institution: Kaohsiung Chang Gung Memorial Hospital

Hypothesis

Does combining platelet-rich plasma with extracorporeal shockwave therapy provide better outcomes for athletes with patellar tendinopathy than platelet-rich plasma alone?

Conclusion

Combining platelet-rich plasma with extracorporeal shockwave therapy leads to faster pain relief in athletes with patellar tendinopathy compared to using platelet-rich plasma alone.

Supporting Evidence

  • Both treatment groups showed significant pain relief after treatments.
  • PRP combined with ESWT resulted in faster reduction of knee pain at the 1-month follow-up.
  • Serum IL-33 showed no significant difference at the 12-month follow-up.
  • Levels of IL-6, IL-15, and IL-17 increased at the 12-month follow-up.
  • No adverse effects were noted in the study.
  • All athletes remained blinded until the final follow-up at 1 year.
  • Participants were randomized into two groups to ensure homogeneity.

Takeaway

This study shows that giving athletes a special treatment called platelet-rich plasma along with shockwave therapy can help them feel better faster when they have knee pain.

Methodology

A randomized controlled trial with 33 athletes divided into two groups: one receiving platelet-rich plasma and sham therapy, and the other receiving platelet-rich plasma with shockwave therapy.

Potential Biases

Potential biases due to the single-center design and lack of standardized treatment protocols.

Limitations

The sample size was small and the follow-up period was limited to one year.

Participant Demographics

Athletes aged 15 to 25 with chronic patellar tendinopathy.

Statistical Information

P-Value

p<0.05

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.1186/s43019-024-00252-3

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication